VYCOR MEDICAL INC Quarterly Entity Common Stock, Shares Outstanding from Q3 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Vycor Medical Inc quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2011 to Q3 2024.
  • Vycor Medical Inc Entity Common Stock, Shares Outstanding for the quarter ending November 13, 2024 was 33.4M shares, a 2.28% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 33.4M +744K +2.28% Nov 13, 2024 10-Q 2024-11-13
Q2 2024 32.6M 0 0% Aug 13, 2024 10-Q 2024-08-13
Q1 2024 32.6M 0 0% Apr 16, 2024 10-K 2024-04-16
Q3 2023 32.6M +102K +0.31% Nov 13, 2023 10-Q 2023-11-13
Q2 2023 32.6M Aug 11, 2023 10-Q 2023-08-11
Q1 2023 32.6M +1.17M +3.73% Apr 14, 2023 10-K 2023-04-14
Q3 2022 32.5M +1.78M +5.78% Nov 11, 2022 10-Q 2022-11-14
Q1 2022 31.5M +3.56M +12.8% Apr 13, 2022 10-K 2022-04-13
Q3 2021 30.7M +3.85M +14.3% Nov 12, 2021 10-Q 2021-11-12
Q1 2021 27.9M +2.61M +10.3% Mar 30, 2021 10-K 2021-03-31
Q3 2020 26.9M +2.14M +8.66% Nov 13, 2020 10-Q 2020-11-13
Q2 2020 26.4M +2.14M +8.85% Aug 12, 2020 10-Q 2020-08-17
Q1 2020 25.3M +2.15M +9.28% Mar 20, 2020 10-K 2020-03-27
Q3 2019 24.8M +2.15M +9.5% Nov 8, 2019 10-Q 2019-11-12
Q2 2019 24.2M +2M +9% Aug 8, 2019 10-Q 2019-08-09
Q1 2019 23.1M +3.07M +15.3% Mar 22, 2019 10-K 2019-03-29
Q3 2018 22.6M +2.79M +14.1% Nov 9, 2018 10-Q 2018-11-13
Q2 2018 22.2M +2.51M +12.7% Aug 10, 2018 10-Q 2018-08-10
Q1 2018 20.1M +2.66M +15.3% Mar 23, 2018 10-K 2018-03-30
Q3 2017 19.8M +8.6M +76.6% Nov 6, 2017 10-Q 2017-11-13
Q2 2017 19.7M +8.6M +77.4% Aug 11, 2017 10-Q 2017-08-11
Q1 2017 17.4M +6.48M +59.2% Mar 27, 2017 10-K 2017-03-31
Q3 2016 11.2M +326K +2.99% Nov 11, 2016 10-Q 2016-11-14
Q2 2016 11.1M +263K +2.42% Aug 5, 2016 10-Q 2016-08-09
Q1 2016 10.9M +141K +1.31% Mar 25, 2016 10-K 2016-03-30
Q3 2015 10.9M +33.8K +0.31% Nov 11, 2015 10-Q 2015-11-13
Q2 2015 10.8M +112K +1.04% Aug 14, 2015 10-Q 2015-08-14
Q1 2015 10.8M +611K +6% Mar 27, 2015 10-K 2015-03-31
Q3 2014 10.9M +4.28M +65% Nov 10, 2014 10-Q 2014-11-12
Q2 2014 10.7M +4.26M +65.7% Aug 8, 2014 10-Q 2014-08-12
Q1 2014 10.2M +4.26M +72% Apr 4, 2014 10-K 2014-04-07
Q3 2013 6.58M -838M -99.2% Nov 11, 2013 10-Q 2013-11-15
Q2 2013 6.48M -856M -99.2% Aug 9, 2013 10-Q 2013-08-14
Q1 2013 5.92M -832M -99.3% Mar 20, 2013 10-K 2013-04-01
Q3 2012 845M +38.9M +4.82% Nov 9, 2012 10-Q 2012-11-14
Q2 2012 862M Aug 6, 2012 10-Q 2012-08-14
Q1 2012 837M Mar 23, 2012 10-K 2012-03-30
Q3 2011 806M Nov 4, 2011 10-Q/A 2011-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.